Cargando…

Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease

Paget's disease (PD) is characterized by increased numbers of abnormal osteoclasts (OCLs) that drive exuberant bone formation, but the mechanisms responsible for the increased bone formation remain unclear. We previously reported that OCLs from 70% of PD patients express measles virus nucleocap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagata, Yuki, Miyagawa, Kazuaki, Ohata, Yasuhisa, Petrusca, Daniela N., Pagnotti, Gabriel M., Mohammad, Khalid S., Guise, Theresa A., Windle, Jolene J., David Roodman, G., Kurihara, Noriyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887003/ https://www.ncbi.nlm.nih.gov/pubmed/33107091 http://dx.doi.org/10.1002/jcb.29861

Ejemplares similares

Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation
por: Miyagawa, Kazuaki, et al.
Publicado: (2023)

ADAM8 Enhances Osteoclast Precursor Fusion and Osteoclast Formation In Vitro and In Vivo
por: Ishizuka, Hisako, et al.
Publicado: (2011)

Blocking the ZZ Domain of Sequestosome1/p62 Suppresses Myeloma Growth and Osteoclast Formation In Vitro and Induces Dramatic Bone Formation in Myeloma-Bearing Bones In Vivo
por: Teramachi, Jumpei, et al.
Publicado: (2015)

Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts
por: Delgado-Calle, Jesus, et al.
Publicado: (2019)

The Role of TGF-β in Bone Metastases
por: Trivedi, Trupti, et al.
Publicado: (2021)

Pathobiology of Paget's Disease of Bone
por: Galson, Deborah L., et al.
Publicado: (2014)

Mechanical suppression of breast cancer cell invasion and paracrine signaling to osteoclasts requires nucleo-cytoskeletal connectivity
por: Yi, Xin, et al.
Publicado: (2020)

Alternative splicing in osteoclasts and Paget’s disease of bone
por: Klinck, Roscoe, et al.
Publicado: (2014)

Role of the Endocannabinoid/Endovanilloid System in the Modulation of Osteoclast Activity in Paget’s Disease of Bone
por: Paoletta, Marco, et al.
Publicado: (2021)

Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice
por: Arellano, Danna L., et al.
Publicado: (2022)

Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis
por: Petrusca, Daniela N, et al.
Publicado: (2018)

Cadherin-6 Mediates the Heterotypic Interactions between the Hemopoietic Osteoclast Cell Lineage and Stromal Cells in a Murine Model of Osteoclast Differentiation
por: Mbalaviele, Gabriel, et al.
Publicado: (1998)

The Paget's disease of bone risk gene PML is a negative regulator of osteoclast differentiation and bone resorption
por: Wani, Sachin, et al.
Publicado: (2022)

Optineurin Negatively Regulates Osteoclast Differentiation by Modulating NF-κB and Interferon Signaling: Implications for Paget’s Disease
por: Obaid, Rami, et al.
Publicado: (2015)

The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease
por: Fu, Jing, et al.
Publicado: (2023)

Effect of a rare genetic variant of TM7SF4 gene on osteoclasts of patients with Paget’s disease of bone
por: Laurier, Emilie, et al.
Publicado: (2017)

Genetic regulatory mechanisms in human osteoclasts suggest a role for the STMP1 and DCSTAMP genes in Paget’s disease of bone
por: Mullin, Benjamin H., et al.
Publicado: (2019)

Anti-osteoclastic agent, denosumab, for a giant cell tumor of the bone with concurrent Paget's disease: A case report
por: Tanaka, Takaaki, et al.
Publicado: (2017)

c-Fms Signaling Mediates Neurofibromatosis Type-1 Osteoclast Gain-In-Functions
por: He, Yongzheng, et al.
Publicado: (2012)

Myosins in Osteoclast Formation and Function
por: Lee, Beth S.
Publicado: (2018)

Translational Strategies to Target Metastatic Bone Disease
por: Pagnotti, Gabriel M., et al.
Publicado: (2022)

ERK5 Activation Is Essential for Osteoclast Differentiation
por: Amano, Shigeru, et al.
Publicado: (2015)

The role of bisphosphonates in breast cancer: Actions of bisphosphonates in animal models of breast cancer
por: Padalecki, Susan S, et al.
Publicado: (2002)

4-Hydroxyderricin inhibits osteoclast formation and accelerates osteoblast differentiation
por: Hagiwara, Hiromi, et al.
Publicado: (2018)

Disease-related PSS1 mutant impedes the formation and function of osteoclasts
por: Sugahara, Sari, et al.
Publicado: (2023)

Paget's disease of bone /
por: Singer, Frederick R., 1939-
Publicado: (1977)

PAGET'S DISEASE OF BONE
Publicado: (1970)

The spine in Paget’s disease
por: Dell’Atti, C., et al.
Publicado: (2007)

Paget's disease of the mandible
por: Karunakaran, K, et al.
Publicado: (2012)

Paget's disease of the breast
por: Karakas, Cansu
Publicado: (2011)

Perianal Paget's Disease
por: Kim, Chang Woo, et al.
Publicado: (2014)

Paget-Schroetter Syndrome
por: Meena, Manoj, et al.
Publicado: (2015)

Sir James Paget
por: Woodhead, G. Sims
Publicado: (1900)

Paget's Disease of the Nipple
por: Munro, Robert
Publicado: (1881)

Paget's Disease of the Nipple
por: Munro, Robert
Publicado: (1882)

Extramammary Paget’s disease
por: Vasquez, Andres, et al.
Publicado: (2016)

Dermoscopy of Paget's Disease
por: Bhat, Yasmeen J., et al.
Publicado: (2020)

Sir James Paget
Publicado: (1881)

Paget's Disease of the Skull
por: Nakatsuji, Yoshiyuki, et al.
Publicado: (2021)

Paget disease of bone
por: Pishdad, Reza, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ijkgn975cosjtpe7bv2q858hrs